Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study Ignacio Marín-Jiménez; Manuel Barreiro-de Acosta; María Esteve; Luisa Castro-Laria; Santiago García-López; Daniel Ceballos; Ana Echarri; María Dolores Martín-Arranz; David Busquets; Jordina Llaó; Mercè Navarro-Llavat; José María Huguet; Federico Argüelles-Arias; Raquel Vicente; José Miguel Boudet; Gema Díaz; Ana M. Sánchez-Migallón; Francesc Casellas;

De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice Alex Arenas; María José Moreta; Ingrid Ordás; Agnès Fernández-Clotet; Berta Caballol; Marta Gallego; Alejandro Vara; Rebeca Barastegui; Angel Giner; Cristina Prieto; Maria Carme Masamunt; Roberto Candia; Elena Ricart;

Adherence to subcutaneous biologic treatment for inflammatory bowel disease Laura Ramos; Javier Ramos-Rodríguez; Raquel De La Barreda; Fernando Gutiérrez-Nicolás; Marta Carrillo-Palau; Inmaculada Alonso-Abreu; Julia Nazco-Casariego; Enrique Quintero;